Doxycycline hyclate is used to treat the following infections:
Respiratory tract infections, skin infections, urinary tract infections, and skin and soft tissue infections caused by susceptible bacteria. In addition to this medication, there may be other uses for this drug. Talk to your doctor or pharmacist if you have any concerns.
Doxycycline may reduce the effectiveness of oral antibiotics. Consult your doctor before combining this medication with other treatments for your infection. Antibiotics can also have side effects, including diarrhea, nausea, and an upset stomach. Talk to your doctor before taking this medication if you have any concerns.
Respiratory tract infections:This medication can be taken orally to treat respiratory tract infections, skin infections, urinary tract infections, and skin and soft tissue infections caused by susceptible bacteria. If you are taking this medication, you should not take this medication unless it has been shown to be effective in treating your infection. Your doctor will determine the best course of treatment for you based on your medical condition and how well your body responds to treatment. The most common side effects include nausea, vomiting, diarrhea, and stomach pain. Talk to your doctor about the risks and benefits of using this medication.
Your doctor will determine the best course of treatment based on your medical condition and how well your body responds to treatment.
What is Doxycycline?
Doxycycline is a broad-spectrum antibiotic that treats a wide range of bacterial infections. It is used to treat a variety of infections caused by susceptible bacteria. Some common uses of doxycycline include:
Ask your health care provider any questions you may have about how to use doxycycline.
This medication may not be right for everyone. If you have certain health conditions or are taking other medications, talk to your health care provider before using doxycycline. This includes prescription and over-the-counter medications, vitamins, and herbal supplements. Your doctor may need to change the dose of your medication or monitor you carefully for side effects.
Doxycycline may cause side effects.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Out of stock
This is a prescription medicine. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "" page before ordering this item.
All of our products are APVMA or TGA approved and identical to those used by your veterinarian. Please call or email us if you have any queries about any of the products on our site.
| sku | 2424 |
|---|---|
| Tax Class | Taxable Goods |
| Indications | Treatment of bacterial infections caused by organisms sensitive to doxycycline in dogs and cats, including infections of the skin, upper and lower respiratory tract, genitourinary tract, middle ear, skeletal system and brain, stomach, intestines, and vomiting GI tract. |
| Refrigeration Required | No |
| Poisons Schedule | S4 |
| Precautions | The use of tetracyclines in young animals (5 to 17 years old) may cause permanent discolouration of the teeth. Doxycycline may cause some yellowing of the teeth and gums. Gastrointestinal side effects (such as nausea, vomiting, diarrhea, stomach upsets, or regurgitation of food) may also occur. The most common gastrointestinal side effects (urticatoxin), and the other 2Frank-Dyerreen syndrome and ErISION syndrome, respectively, are described below. |
| Type of Poisons | Non-steroidal anti-inflammatory drugs |
| Common Quotient | Doxycycline |
| Common Category | |
| The use of tetracycline drugs in young animals (5 to 17 years old) may cause permanent teeth discoloration. The most common gastrointestinal side effects (urticatoxin) and the other 2Frank-Dyerreen syndrome and ErISION syndrome, respectively, are described below. | |
| Type of Poisonser | Veterinary |
| Prenatal Test | Adult tests only |
| Child Category | Hepatic ketosis, jock itch, adult hepatitis |
| Prenatal Dosing | 200 mg/kg/day |
| Child No. |
Hard gelatin capsule with opaque green cap and opaque green body with "100mg" printed in white ink.Therapeutic indicationsDoxycycline has been found clinically effective in the treatment of a variety ofinfections caused by susceptible strains of Gram-positive and Gram-negative bacteriaand certain other micro- organisms. Respiratory tract infections Pneumonia and other lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae and other organisms. Mycoplasma pneumoniae pneumonia. Treatment of chronic bronchitis, sinusitis. Urinary tract infections Infections caused by susceptible strains of Klebsiella species, Enterobacter species. Escherichia coli, Streptococcus faecalis and other organisms. Sexually transmitted diseases Infections due to Chlamydia trachomatis including uncomplicated urethral, endocervical or rectal infections. Non-gonococcal urethritis caused by Ureaplasma urealyticum (T- mycoplasma). Doxycycline is also indicated in chancroid, granuloma inguinale and lymphogranuloma venereum. Doxycycline is an alternative drug in the treatment of gonorrhoea and syphilis. Dermatological infections Acne vulgaris when antibiotic therapy is considered necessary. Since Doxycycline is a member of the tetracycline group of antibiotics, it may be expected to be useful in the treatment of infections, which respond to other tetracyclines, such as: Ophthalmic infections Due to susceptible strains of gonococci, staphylococci and Haemophilus influenzae. Doxycycline Capsules are indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. Rickettsial infections Rocky Mountain spotted fever, typhus group, Q fever, Coxiella endocarditis and tick fevers. Other infections Psittacosis, cholera, meliodosis, leptospirosis, other infections due to susceptible strains of Yersinia species, Brucella species (in combination with Streptomycin), Clostridium species, Francisella tularensis and chloroquine-resistant falciparum malaria. Doxycycline Capsules are indicated for prophylaxis in the following conditions: Scrub typhus, travellers' diarrhoea (enterotoxigenic Escherichia coli), leptospirosis. Consideration should be given to official guidance on the appropriate use of antibacterial agents.FeaturesNature and contents of container• Doxycycline capsules are packed in blister packs made of one sheet of 200 micron rigid, opaque white polyvinyl chloride and a second sheet of 20 micron aluminium.• Pack size 8 capsule. Special precautions for storage• Store below 25°C. Patient Information Leaflet:https://www.medicines.org.uk/emc/product/4063/pil
Doxycycline capsules - Pack size: 8 capsule. Excipient per pack•Contains: Phenoxyisomer p-isopropyl carbodimeth stirfum,isosorbide dinitrate,isopropyl alcohol,merck drug\Active ingredient:doxycycline hydrochloride,which has been dissolved in water,water and ethanol. Special measures should be taken to avoid recurrence of infection. For cholera: 50 mg Doxycycline capsules should be administered with food. For pneumonia: 100 mg Doxycycline capsules should be administered with food. For sulfadoxine-induced epilepsy: 100 mg Doxycycline capsules should be administered with food. For Bacteroides the suspension should be taken up to 30 mg/1pnglz. The higher the pNglz the lower the dosage of Doxycycline will need to be adjusted. For Inhesis: 200 mg Doxycycline capsules should be administered with water. For infectious mononucleosis in men: 100 mg Doxycycline capsules should be administered with water. For infections of the skin and soft tissue: 50 mg Doxycycline capsules should be administered with water. For feline lymphogranuloma venereum infections: 100 mg Doxycycline capsules should be administered with water. For infections of the skin and soft tissues: 50 mg Doxycycline capsules should be administered with water. For infections of the genital organs: 50 mg Doxycycline capsules should be administered with water.The global Doxycycline market is experiencing significant growth driven by rising awareness of the antibiotic, rising antibiotic resistance, and expanding access to effective treatment options. The market is projected to reach USD 2.9 billion by 2034, and is expected to grow from USD 1.2 billion in 2023 to USD 3.6 billion by 2034, growing at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period 2024-2031.
The global Doxycycline market is projected to reach USD 1.2 billion by 2034, driven by increasing prevalence of respiratory diseases, rising antibiotic resistance, and expanding access to essential medicines. The market is expected to continue growing at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The CAGR for the 2023-2034 forecasted growth rate of 4.2% is anticipated to continue the market growth.
The global Doxycycline market is characterized by the presence of both oral and injectable formulations. The injectable formulation is crucial in the management of respiratory infections such as pneumonia, bronchitis, and sinusitis, while the oral formulation is crucial in the treatment of skin infections and tooth infections. The demand for Doxycycline in the market is driven by various factors, including the rising prevalence of respiratory diseases, rising antibiotic resistance, and the expanding availability of oral medications for the treatment of various bacterial infections.
The Doxycycline market is segmented into respiratory and skin infections. Respiratory diseases are becoming increasingly common, and Doxycycline is becoming a popular treatment option for both conditions. The use of Doxycycline in the treatment of respiratory infections is also expected to increase, as it is effective against bacteria that may cause these conditions. The skin infections segment is also expanding, with a growing focus on managing the spread of fungal infections. The skin infections segment is also highly valued for its efficacy in treating infections caused by fungi, such as rosacea. The dental segment is highly valued for its efficacy in treating dental infections, as it can prevent infection after dental procedures.
The global Doxycycline market is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The CAGR for the 2023-2034 is expected to continue the market growth during the forecast period.
The market is driven by increasing awareness of antibiotics, rising antibiotic resistance, and the development of new and innovative treatments. The rising prevalence of respiratory diseases, the rise in antibiotic resistance, and expanding access to effective treatment options are leading factors that are driving the growth of the market. The rise of respiratory diseases and rising antibiotic resistance have significantly impacted the demand for effective treatment options, leading to a higher demand for these treatments in the market.
The rapid development of new antibiotic-related drugs is expected to drive the market growth in the next several years, as new formulations, new indications, and improved formulation options are becoming available. The increasing prevalence of bacterial infections, rising rates of antimicrobial resistance, and the growing incidence of skin and oral infections are also contributing factors. The rising incidence of respiratory infections, such as bronchitis, pneumonia, and sinusitis, has further driven the demand for effective treatment options, as more individuals are seeking convenient and effective ways to treat their conditions.
The increasing prevalence of respiratory diseases, rising antibiotic resistance, and expanding access to effective treatment options are expected to drive the market growth in the next several years. The increasing incidence of bacterial infections, the rise in antibiotic resistance, and the expanding availability of oral medications for respiratory conditions are contributing factors. The rising prevalence of respiratory diseases, the rising incidence of bacterial infections, and the expanding access to effective treatment options are driving the demand for effective treatments in the market.
The market is expected to grow significantly at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The CAGR for the 2023-2034 forecasted growth rate of 4.2% is expected to continue the market growth.
What is the price of doxycycline hyclate 100mg?
You can get doxycycline hyclate 100mg from the online drugstore and buy it at the lower price. We offer the highest quality products from top Indian pharmaceutical companies. The price of doxycycline hyclate 100mg can be as low as 25-50 percent. We recommend you to buy doxycycline hyclate 100mg at the lowest price. You can find the best price of doxycycline hyclate 100mg by going to the online drugstore and buying it at the lower price. Buy doxycycline hyclate 100mg at the lowest price.
What are the side effects of doxycycline hyclate?
The most common side effects of doxycycline hyclate 100mg include:
We have a comprehensive list of adverse effects of doxycycline hyclate 100mg at the lowest price online.
Stade de France Pharmacy